Cooperation with Phyton:
FROM PLANT CELLS TO TUMOR THERAPEUTICS
Phyton Biotech GmbH, with production headquarters in Ahrensburg (Germany), is the world market leader when it comes to the fermentation of plant cells. Only a few companies dare to tackle the fermentation of active plant ingredients, as it is costly, technically highly complex and tedious. KIT's novel microfluidics opens up new possibilities in this field.
Together with experts from Phyton Biotech, researchers from KIT were given the opportunity to do so in a joint project funded by the German Federal Ministry of Education and Research (BMBF).
Building on the existing prototype, they further developed the microreactor to optimize the paclitaxel fermentation process in particular.
For Phyton Biotech, cooperation with research institutions such as KIT is worthwhile: "In the scientific field you often find very specialized expertise. In such projects, we can participate in it and use it for our further entrepreneurial development. That is a great treasure. We could not do such research work ourselves," says Ph. D. Gilbert Gorr of Phyton Biotech. In return, KIT scientists benefit from application-oriented research that would not be possible without such cooperations. Above all, young scientists are promoted as a result.
